Visually guided inspiration breath-hold facilitated with nasal high flow therapy in locally advanced lung cancer

• Published in: Acta oncologica 2021-05, Vol.60 (5), p.567-574
• Main Authors: Peeters, Stephanie T. H., Vaassen, Femke, Hazelaar, Colien, Vaniqui, Ana, Rousch, Eva, Tissen, Debby, Van Enckevort, Esther, De Wolf, Michiel, Öllers, Michel C., van Elmpt, Wouter, Verhoeven, Karolien, Van Loon, Judith G. M., Vosse, Bettine A., De Ruysscher, Dirk K. M., Vilches-Freixas, Gloria
• Format: Article
• Language: English
• Subjects: breath hold; Breath Holding; Carcinoma, Non-Small-Cell Lung - diagnostic imaging; Carcinoma, Non-Small-Cell Lung - radiotherapy; Humans; Lung cancer; Lung Neoplasms - radiotherapy; Prospective Studies; radiotherapy; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; surface scanning
• ISSN: 0284-186X; 1651-226X
• DOI: 10.1080/0284186X.2020.1856408

Reducing breathing motion in radiotherapy (RT) is an attractive strategy to reduce margins and better spare normal tissues. The objective of this prospective study (NCT03729661) was to investigate the feasibility of irradiation of non-small cell lung cancer (NSCLC) with visually guided moderate deep inspiration breath-hold (IBH) using nasal high-flow therapy (NHFT). Locally advanced NSCLC patients undergoing photon RT were given NHFT with heated humidified air (flow: 40 L/min with 80% oxygen) through a nasal cannula. IBH was monitored by optical surface tracking (OST) with visual feedback. At a training session, patients had to hold their breath as long as possible, without and with NHFT. For the daily cone beam CT (CBCT) and RT treatment in IBH, patients were instructed to keep their BH as long as it felt comfortable. OST was used to analyze stability and reproducibility of the BH, and CBCT to analyze daily tumor position. Subjective tolerance was measured with a questionnaire at 3 time points. Of 10 included patients, 9 were treated with RT. Seven (78%) completed the treatment with NHFT as planned. At the training session, the mean BH length without NHFT was 39 s (range 15-86 s), and with NHFT 78 s (range 29-223 s) (p = .005). NHFT prolonged the BH duration by a mean factor of 2.1 (range 1.1-3.9s). The mean overall stability and reproducibility were within 1 mm. Subjective tolerance was very good with the majority of patients having no or minor discomfort caused by the devices. The mean inter-fraction tumor position variability was 1.8 mm (-1.1-8.1 mm;SD 2.4 mm). NHFT for RT treatment of NSCLC in BH is feasible, well tolerated and significantly increases the breath-hold duration. Visually guided BH with OST is stable and reproducible. We therefore consider this an attractive patient-friendly approach to treat lung cancer patients with RT in BH.